The Bill and Melinda Gates Foundation is to award $156 million for research on malaria vaccines as part of a 30 percent rise in its annual malaria budget.
The 5-year grant will go to the PATH Malaria Vaccine Initiative. The not-for-profit organisation is working to develop vaccines that would prevent malaria infections in humans and stop mosquitoes from transmitting the disease between humans.
The MVI’s 2013 budget was $315m, and it has received high marks from charity watchdogs for spending its money responsibly. The organization was sharply criticized, however, for possibly violating consent rules in a 2010 human papilloma virus trial in India in which 7 girls died.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.